Last updated on June 2018

Non-Interventional Study on the Tolerability and Efficacy of IVIG


Brief description of study

Non-Interventional Study on the Tolerability and Efficacy of octagam 10%

Detailed Study Description

A Non-Interventional Study on the Tolerability and Efficacy of Octagam 5% or 10% or panzyga. Patients with any indication (replacement and immonomodulation) as prescribed by the treating physician. Marketed Octagam 5% or 10% or panzyga will be used according to the investigator prescription; intravenous (iv) administration.The primary objective is to detect and evaluate adverse drug reactions (ADRs) occurring during or after the administration of Octagam or panzyga in any indication, age group or treatment regimen, where a causal relationship to the administration of Octagam or panzyga is suspected.

Clinical Study Identifier: NCT02303093

Contact Investigators or Research Sites near you

Start Over

Octapharma Research Site

Béziers, France
2.53miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.